Neurodegenerative Diseases
World Drug Market 2011-2026
Would you like to know how the industry and market for neurodegenerative drug treatments will develop? There will be trends to watch from 2010 onwards, especially areas of revenue growth.... | Nov 2010 |
£1,499 |
Alzheimer’s Disease Patients & Market Worldwide
Future Scenario (2010 – 2015) & Drugs Analysis
Alzheimer’s is a complex disease and there is no single “magic bullet” available in the market to prevent or cure it. Though many marketed drugs have been approved for Alzheimer’s... | Jun 2011 |
£610 |
GSK's Cervarix
A Future Blockbuster of 2007
Please Note: Reports are sold based on the user licenses indicated. The reports will be accessible in Flash format via an online reading room on the publisher website, allowing viewing... | Mar 2007 |
£1,999 |
Opportunities in Orphan Drugs: Strategies for developing maximum returns from niche indications
The US government introduced the Orphan Drugs Act (ODA) in 1983 as a means to provide incentives to drug developers so that they would develop treatments for diseases for which... | Jan 2010 |
£2,465 |
Healthcare in a Recession
(OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)
Current economic conditions dominate business strategies. While healthcare has fared better than other industries, it will not be immune from the effects of the current recession. But what... | Mar 2009 |
£1,280 |
World Vaccines Market
Vaccine Segments Analysis, Vaccine Cases and Future Forecast
Vaccine Industry - Market Overview
For decades vaccines were a neglected corner of the drugs business, with old technology, little investment and abysmal profit margins. Many firms sold their vaccine divisions... | Jan 2010 |
£705 |
Global Vaccine Market Outlook (2007-2010)
| Nov 2007 |
£515 |
Pharmaceutical Market Trends, 2010 - 2014
Key market forecasts & growth opportunities (4th Edition)
| Oct 2010 |
£1,495 |
Pipeline Insight: Osteoarthritis
The Wait for a DMOAD Continues
| Nov 2006 |
£7,325 |
FDA ends the 50-year long wait for Lupus patients
Benlysta set to become the next blockbuster
| Mar 2011 |
£320 |
Gastrointestinal Disorders Market Intelligence to 2012
| May 2007 |
£1,499 |
The World Antibacterial Treatments Market
2010-2024
| Dec 2009 |
£1,499 |
World Gastrointestinal Disorders Market 20082023
| Oct 2008 |
£1,499 |
Indication Expansion
Opportunities for successful lifecycle management
| Mar 2007 |
£1,225 |
Live-Licensing & In-life Testing
R&D Processes and Regulation for New Drugs, 2008-2020
| Jan 2008 |
£1,499 |
2008 Trends to Watch: Pharmaceutical Technology
| Jan 2008 |
£1,220 |
The Antipsychotics Market Insight & Analysis 2008
| Feb 2008 |
£1,499 |
Australia Generics Market
| Mar 2011 |
£4,175 |
Rimonabant: The first of the Cannabinoid blockbusters
| Jun 2007 |
£1,499 |
Global Generics Industry Report
| Sep 2006 |
£550 |
Global Ophthalmic Market Analysis & Forecasts to 2012
| Apr 2007 |
£1,499 |
Pharmaceuticals
| Sep 2008 |
£1,255 |
AMD Market Outlook to 2012
| Mar 2007 |
£1,299 |
Global Smoking Cessation Market Analysis & Forecasts
Preparing For The First Blockbuster
| Jul 2007 |
£1,499 |
